S

StemRIM Inc
TSE:4599

Watchlist Manager
StemRIM Inc
TSE:4599
Watchlist
Price: 365 JPY 0.55% Market Closed
Market Cap: 22.5B JPY
Have any thoughts about
StemRIM Inc?
Write Note

StemRIM Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

StemRIM Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
S
StemRIM Inc
TSE:4599
Income from Continuing Operations
-ÂĄ2B
CAGR 3-Years
-51%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Income from Continuing Operations
ÂĄ5.4B
CAGR 3-Years
51%
CAGR 5-Years
51%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Income from Continuing Operations
ÂĄ17.1B
CAGR 3-Years
40%
CAGR 5-Years
46%
CAGR 10-Years
64%
Takara Bio Inc
TSE:4974
Income from Continuing Operations
ÂĄ145m
CAGR 3-Years
-79%
CAGR 5-Years
-49%
CAGR 10-Years
-22%
Pharma Foods International Co Ltd
TSE:2929
Income from Continuing Operations
ÂĄ3.2B
CAGR 3-Years
-6%
CAGR 5-Years
45%
CAGR 10-Years
80%
C
Cuorips Inc
TSE:4894
Income from Continuing Operations
-ÂĄ632.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

StemRIM Inc
Glance View

Market Cap
22.5B JPY
Industry
Biotechnology

StemRIM, Inc. engages in the research and development of regeneration inducing medicine. The company is headquartered in Ibaraki-Shi, Osaka-Fu and currently employs 46 full-time employees. The company went IPO on 2019-08-09. The firm is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.

Intrinsic Value
151.2 JPY
Overvaluation 59%
Intrinsic Value
Price
S

See Also

What is StemRIM Inc's Income from Continuing Operations?
Income from Continuing Operations
-2B JPY

Based on the financial report for Jul 31, 2024, StemRIM Inc's Income from Continuing Operations amounts to -2B JPY.

What is StemRIM Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-23%

The average annual Income from Continuing Operations growth rates for StemRIM Inc have been -51% over the past three years , -23% over the past five years .

Back to Top